BioSpace News Archive

United Therapeutics Corporation announced that James Edgemond, Chief Financial Officer and Treasurer of United Therapeutics, will provide an overview and update on the company’s business at the Jefferies 2019 Healthcare Conference in New York City.

Company Strengthens Market Positioning and Strategic Growth Potential Behind Single Powerful Brand

VDF FutureCeuticals, global leader in the research and development of natural, scientifically validated ingredients for the advancement of human health, is proud to announce that its Research & Analytical Center and methods have been certified under ISO/IEC 17025:2017.

Designation recognizes products that bring improvements to the health care industry

Evogene Ltd., a leading biotechnology company developing novel products for life science markets, announced its financial results for the first quarter ending March 31, 2019.

CollPlant announced that Dr. Nadav Orr, presented the utilization of CollPlant’s recombinant human collagen (rhCollagen) in the field of 3D Bioprinting tissues and organs at the Annual Meeting of the Tissue Engineering and Regenerative Medicine International Society (TERMIS) European Union Chapter in Rhodes, Greece on Monday, May 27, 2019.

Intec Pharma Ltd. announces that Company management will participate at the following upcoming investment conferences in June.

Final 190,000 sq. ft. Greenhouse Licensed. Total of 700,000 sq. ft. of Production and Processing Infrastructure Now Fully Licensed

Cognizance Biomarkers, LLC, a wholly-owned subsidiary of Evogen, Inc., reported it presented data at the 2019 Antiepileptic Drug and Device Trials XV Conference that supports the further development of a biomarker monitoring test to assess seizure burden in epilepsy patients.

Cadent Therapeutics announced that Jodie Morrison, the Company’s Chief Executive Officer, will present at the Jefferies Healthcare Conference on Tuesday, June 4, 2019 at 10:00 am ET in New York City.